Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
B TennantJ L Gerin

Abstract

Woodchucks were used to study the antiviral activity and toxicity of fialuridine (FIAU; 1,-2'deoxy-2'fluoro-1-beta-D-arabinofuranosyl-5-iodo-uracil). In an initial experiment, groups of six chronic woodchuck hepatitis virus (WHV) carrier woodchucks received daily doses of FIAU by intraperitoneal injection for 4 weeks. At 0.3 mg/kg/d, the antiviral effect was equivocal, but at 1.5 mg/kg/d, FIAU had significant antiviral activity. No evidence of drug toxicity was observed during the 4-week period of treatment or during posttreatment follow-up. In a second experiment, groups of nine WHV carriers or uninfected woodchucks were given 1.5 mg/kg/d of FIAU orally for 12 weeks, and the results compared with placebo-treated controls. After 4 weeks, the serum WHV-DNA concentration in the FIAU-treated carrier group was two to three logs lower than that in the placebo-treated group. After 12 weeks of FIAU treatment, serum WHV DNA was not detectable by conventional dot-blot analysis, hepatic WHV-DNA replicative intermediates (RI) had decreased 100-fold, and hepatic expression of WHV core antigen was remarkably decreased. No evidence of toxicity was observed after 4 weeks, but, after 6 to 7 weeks, food intake decreased and, after 8 weeks, the ...Continue Reading

References

Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J SummersR Snyder
Dec 1, 1992·Journal of the American Society of Nephrology : JASN·R GopinathM Halperin
Aug 15, 1991·Annals of Internal Medicine·K K LaiT P Cooley
Jun 16, 1990·Lancet·P Jolliet, J J Widmann
Sep 1, 1988·The Journal of Clinical Investigation·B E CorkeyC A Stanley
Feb 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·H PopperJ L Gerin
Jan 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J E HeubiW K Schubert
Aug 1, 1986·Analytical Biochemistry·M S ChenS C Oshana
May 1, 1995·Nature Medicine·W Lewis, M C Dalakas
Dec 1, 1994·Antimicrobial Agents and Chemotherapy·J L MartinJ E Reardon
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·F C RichardsonR R Bowsher
Jan 1, 1993·Annals of Internal Medicine·G ChatthaL M Tierney
Jun 1, 1996·Toxicology in Vitro : an International Journal Published in Association with BIBRA·J M ColacinoF C Richardson

❮ Previous
Next ❯

Citations

Aug 18, 2012·Seminars in Immunopathology·Maura DandriJörg Petersen
Feb 18, 1999·Toxicology Letters·D M Morton
Oct 6, 2000·Drug Discovery Today·D E Johnson, G H Wolfgang
Apr 7, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Hong ShenPaul Y Kwo
Apr 9, 2008·Chemical Research in Toxicology·James J KohlerWilliam Lewis
Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M DandriJ Petersen
Jun 15, 2001·ILAR Journal·B C Tennant, J L Gerin
Dec 7, 2007·Antimicrobial Agents and Chemotherapy·Charles E MazzuccoDaniel J Tenney
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·M L BryantJ P Sommadossi
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·John CaseyBrent E Korba
Jun 28, 2005·Antimicrobial Agents and Chemotherapy·Brenda I Hernandez-SantiagoRaymond F Schinazi
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·G L Plaa
Nov 10, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Alberto CorsiniMichele Bortolini
Dec 18, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Rebecca A Torres, William Lewis
Nov 16, 2006·Expert Opinion on Therapeutic Targets·Daniel YerlyAndreas Cerny
Jan 6, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·G Moyle
Feb 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stephan MenneBud C Tennant
Feb 8, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·M DandriJ Petersen
Feb 21, 2008·Biochemical and Biophysical Research Communications·Xing-Xing HeBai-Xin Ye
Jul 6, 2011·Critical Reviews in Toxicology·Robert A Roth, Patricia E Ganey
Sep 17, 2003·The Journal of Toxicological Sciences·Urs A Boelsterli
Jan 27, 2015·Journal of Laboratory Automation·Salman R KhetaniBrenton R Ware
Feb 24, 2001·Clinics in Liver Disease·B C Tennant

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.